Effect of clofarabine when given in as a sequential therapy in combination with HLA-haploidentical hematopoietic stem cell transplantation in patients with lymphoma

Trial Profile

Effect of clofarabine when given in as a sequential therapy in combination with HLA-haploidentical hematopoietic stem cell transplantation in patients with lymphoma

Completed
Phase of Trial: Phase II

Latest Information Update: 25 May 2015

At a glance

  • Drugs Clofarabine (Primary) ; Cyclophosphamide; Fludarabine; Melphalan
  • Indications Acute lymphoblastic leukaemia; Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top